HDAC9 and cholangiocarcinoma: These enzymes become defective by changing cellularprocesses in cancerous cells and high acetylation levels are observedthat inhibits tumors.27,28 In this study, we investigatedthe effects of the combination of HDAC inhibitors and autophagy modulatorson TFK-1 and EGI-1 CCA cell lines.